(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of -20.53% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 2.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 126.6%.
Rockwell Medical's revenue in 2025 is $87,966,000.On average, 1 Wall Street analysts forecast RMTI's revenue for 2025 to be $2,407,025,908, with the lowest RMTI revenue forecast at $2,407,025,908, and the highest RMTI revenue forecast at $2,407,025,908.
In 2026, RMTI is forecast to generate $2,809,172,420 in revenue, with the lowest revenue forecast at $2,809,172,420 and the highest revenue forecast at $2,809,172,420.